CHINA / SOCIETY
Sinovac vaccine well tolerated, safe and induced humoral responses in minors aged 3–17: Lancet
By Globaltimes.cn Published: Jun 29, 2021 07:57 AM
A health worker displays the COVID-19 vaccines developed by China's Sinovac in Bangkok, Thailand, June 26, 2021. (Photo: Xinhua)

A health worker displays the COVID-19 vaccines developed by China's Sinovac in Bangkok, Thailand, June 26, 2021. (Photo: Xinhua)


 
Lancet Infect Dis released the world first trial result on minors aged 3-17 Tuesday. It showed China’s Sinovac COVID-19 vaccine was well tolerated and safe and induced humoral responses in children and adolescents aged 3–17 years.